Citigroup’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.7K Buy
2,426
+180
+8% +$4.06K ﹤0.01% 3983
2025
Q1
$62.9K Buy
2,246
+1,138
+103% +$31.9K ﹤0.01% 4045
2024
Q4
$13.3K Hold
1,108
﹤0.01% 4475
2024
Q3
$18.5K Hold
1,108
﹤0.01% 4411
2024
Q2
$10.9K Buy
1,108
+1
+0.1% +$10 ﹤0.01% 4374
2024
Q1
$16.2K Hold
1,107
﹤0.01% 4338
2023
Q4
$16.1K Hold
1,107
﹤0.01% 4302
2023
Q3
$26.4K Hold
1,107
﹤0.01% 3623
2023
Q2
$14.7K Hold
1,107
﹤0.01% 4325
2023
Q1
$86.5K Sell
1,107
-1
-0.1% -$78 ﹤0.01% 3447
2022
Q4
$92.2K Sell
1,108
-132
-11% -$11K ﹤0.01% 3374
2022
Q3
$114K Sell
1,240
-4,311
-78% -$396K ﹤0.01% 3324
2022
Q2
$830K Sell
5,551
-424
-7% -$63.4K ﹤0.01% 2223
2022
Q1
$1.45M Sell
5,975
-181
-3% -$43.9K ﹤0.01% 2028
2021
Q4
$1.86M Buy
6,156
+233
+4% +$70.5K ﹤0.01% 2030
2021
Q3
$2.45M Buy
5,923
+756
+15% +$313K ﹤0.01% 1756
2021
Q2
$1.58M Buy
5,167
+110
+2% +$33.7K ﹤0.01% 2275
2021
Q1
$1.04M Sell
5,057
-69
-1% -$14.2K ﹤0.01% 2353
2020
Q4
$1.03M Buy
5,126
+98
+2% +$19.6K ﹤0.01% 2155
2020
Q3
$833K Sell
5,028
-57
-1% -$9.44K ﹤0.01% 1979
2020
Q2
$1.26M Sell
5,085
-95
-2% -$23.6K ﹤0.01% 1938
2020
Q1
$945K Buy
5,180
+5,055
+4,044% +$922K ﹤0.01% 1852
2019
Q4
$36K Buy
125
+37
+42% +$10.7K ﹤0.01% 4200
2019
Q3
$24K Sell
88
-74
-46% -$20.2K ﹤0.01% 4188
2019
Q2
$61K Sell
162
-14
-8% -$5.27K ﹤0.01% 3941
2019
Q1
$47K Buy
176
+6
+4% +$1.6K ﹤0.01% 4069
2018
Q4
$37K Sell
170
-8
-4% -$1.74K ﹤0.01% 4102
2018
Q3
$80K Buy
178
+85
+91% +$38.2K ﹤0.01% 3748
2018
Q2
$38K Buy
93
+38
+69% +$15.5K ﹤0.01% 4039
2018
Q1
$30K Buy
55
+51
+1,275% +$27.8K ﹤0.01% 4037
2017
Q4
$2K Buy
4
+3
+300% +$1.5K ﹤0.01% 4824
2017
Q3
$1K Hold
1
﹤0.01% 4629
2017
Q2
$0 Buy
+1
New ﹤0.01% 5000
2016
Q2
Sell
-2
Closed 5321
2016
Q1
$0 Buy
+2
New ﹤0.01% 5640